BULLFROG AI HOLDINGS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BULLFROG AI HOLDINGS, INC. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $3.36M, a 1482.50% increase year-over-year.
- BULLFROG AI HOLDINGS, INC. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $4.22M.
- BULLFROG AI HOLDINGS, INC. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $721.43K.
- BULLFROG AI HOLDINGS, INC. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $212.46K.
- BULLFROG AI HOLDINGS, INC. stock issued during period, value, new issues for fiscal 2025 was $2.45M, a 70.51% decline from fiscal 2024.
- BULLFROG AI HOLDINGS, INC. stock issued during period, value, new issues for fiscal 2024 was $8.32M, a 14.01% increase from fiscal 2023.
- BULLFROG AI HOLDINGS, INC. stock issued during period, value, new issues for fiscal 2023 was $7.29M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $3.36M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $4.22M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $2.45M 10-K · filed 2026-03-19 | |
| 2025-09-30 | $721.43K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $212.46K 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $8.32M 10-K · filed 2026-03-19 | |
| 2024-03-31 | $5.67M 10-Q · filed 2025-11-14 | |
| 2023-12-31 | $7.29M 10-K · filed 2025-03-14 | |
| 2023-03-31 | $7.29M 10-Q · filed 2024-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B |